YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Wearable-derived data provide new insights into how clinical outcomes for patients treated with CAVT and anticoagulation, and anticoagulation alone translate to patients' everyday recovery ALAMEDA, Calif., Oct. 6, 2026 /PRNewswire/ -- Penu…
Investors interested in stocks from the Medical - Instruments sector have probably already heard of Integra LifeSciences (IART) and Penumbra (PEN). But which of these two stocks offers value investors a better bang for their buck right now…
Investors interested in stocks from the Medical - Instruments sector have probably already heard of Integra LifeSciences (IART) and Penumbra (PEN). But which of these two companies is the best option for those looking for undervalued stock…
Zimmer Biomet Holdings Inc HQ photo-by jetcityimage via iStock With a market cap of $18.8 billion, Zimmer Biomet Holdings, Inc. (ZBH) is a global medical technology company specializing in musculoskeletal healthcare solutions. The company…
Penumbra, Inc.'s PEN robust product portfolio expansion is poised to drive growth in the upcoming quarters. The company's international expansion efforts are thriving. Unfavorable foreign exchange and a dull macroeconomic scenario may pose…
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. We have fou…
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. The be…
Q2 Earnings Highlights: ICU Medical (NASDAQ:ICUI) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Let's dig into the relative performance of ICU Medical (NASDAQ:ICUI) and its peers as we unravel the n…
Photo by Pexels on Pixabay The market may be focused on temporary hurdles, but a strategic acquirer would see a unique technology at a strong price. When a company with a first-of-its-kind therapy for a large, underserved market gets hit b…
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. We hav…
AngioDynamics, Inc. ANGO offers investors a clear trade-off. Its Med Tech platforms are expanding quickly, but near-term earnings conversion remains weak as tariffs and operating costs absorb part of the benefit. The investment case depend…
* Penumbra press release [https://seekingalpha.com/pr/20602150-penumbra-inc-reports-second-quarter-2026-financial-results] (PEN [https://seekingalpha.com/symbol/PEN]): Q2 GAAP EPS of $0.88. * Revenue of $390M. * Global thrombectomy revenue…
ALAMEDA, Calif., July 30, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the second quarter ended June 30, 2026.Penumbra, Inc. Revenue of $390.0 million in th…
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Penumbra (PEN) is back in focus after Novant Health reported succes…
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Penumbra (NYSE:PEN) received FDA clearance for its THUNDERBOLT computer-assisted vacuum thrombectom…
Magnendo Corp. MIT spinout to accelerate product development and first-in-human studies of its magnetic robotic navigation platform designed to dramatically improve the speed and reliability of neuro-endovascular proceduresMagnendo Secures…
First and only CAVT device for stroke demonstrated high revascularization rates, short procedure times and low complication rates ALAMEDA, Calif., July 22, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy c…
Investors interested in stocks from the Medical - Instruments sector have probably already heard of IQVIA Holdings (IQV) and Penumbra (PEN). But which of these two stocks is more attractive to value investors? We'll need to take a closer l…
ALAMEDA, Calif., July 7, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will…
GuideAI Health Corp. Leading Vascular Specialist and Penumbra Chief Medical Officer Joins GuideAI to Help Advance Its Recently FDA-Cleared VAOT Triage Software BOSTON, July 06, 2026 (GLOBE NEWSWIRE) -- GuideAI Health Corp. (Cboe CA: GDAI)…
Tuesday, June 30, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corp. (MSFT), Exxon Mobil Corp. (XOM) and D…
Spotting Winners: Merit Medical Systems (NASDAQ:MMSI) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q1 Wrapping up Q1 earnings, we look at the numbers and key takeaways for the medical devices & supplies - card…
Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or Penumbra (PEN). But which of these two stocks presents investors with the better value opportunity right now? Let's tak…
Penumbra, Inc. PEN recently received CE Mark in Europe for THUNDERBOLT, following the FDA approval in the United States last week. THUNDERBOLT is a computer-assisted vacuum thrombectomy (CAVT) technology, designed to address acute ischemic…
ClearPoint Neuro, Inc. CLPT shares rallied 26% in the last trading session to close at $16.81. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stoc…
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders The end of an earnings season can be a great time to discover new stocks and assess how companies are handli…
The THUNDERBOLT TM Computer Assisted Vacuum Thrombectomy (CAVTTM) technology introduces modulated aspiration for acute ischemic stroke for the first time, enabling more rapid, complete clot removal ALAMEDA, Calif., June 15, 2026 /PRNewswir…
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Penumbra received FDA clearance for its Thunderbolt stroke thrombectomy device. Boston Scientific (…
Penumbra's (PEN) Thunderbolt device positions the company as the only one in the US offering compute PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
THUNDERBOLT is the first CAVT platform to deliver modulated aspiration for acute ischemic stroke — enabling faster, more complete clot removal ALAMEDA, Calif., June 11, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading t…
Investors interested in stocks from the Medical - Instruments sector have probably already heard of Globus Medical (GMED) and Penumbra (PEN). But which of these two companies is the best option for those looking for undervalued stocks? Let…
It has been about a month since the last earnings report for Penumbra (PEN). Shares have lost about 1.2% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or i…
Artisan Partners, an investment management company, released its first-quarter 2026 investor letter for the “Artisan Small Cap Fund”. A copy of the letter is available to download here. US equities were mixed in Q1 2026, with major indices…
Boston Scientific BSX continues to prioritize strategic tuck-in M&A as its primary capital allocation focus, supporting entry into adjacencies, expanding technology platforms and enhancing long-term competitive positioning. In April 2026,…
On May 13, 2026, Champlain Investment Partners, LLC, reported selling its entire stake of 1,568,859 shares in ServisFirst Bancshares(NYSE:SFBS), an estimated $124.23 million trade based on quarterly average pricing. Sold 1,568,859 shares o…
Key Points Sold 1,568,859 shares of ServisFirst Bancshares; estimated trade value ~$124.23 million (based on quarterly average price) Quarter-end position value decreased by $112.63 million, reflecting both trading activity and price movem…